Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03678324 · ClinicalTrials.gov registry record · NA
Pre-Clinical White Matter Changes and Associated Connectivity Effects in Fabry Disease
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03678324 is a NA study that has completed, run by University of Utah. The registered enrollment target is 40 participants.
The verdict
NCT03678324, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this research project is: * to use an advanced quantitative MRI technique (FBFI) to detect and quantify brain lesion in patients with FD * to use fMRI to identify altered brain function * to use FBFI and fMRI together to map altered connectivity in response to brain lesions
Interventions
- OTHER Functional MRI and fast bound-pool fraction imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-01-27 |
| Est. Completion | 2022-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03678324
The ClinicalTrials.gov registry entry for NCT03678324 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Functional MRI and fast bound-pool fraction imaging is the first listed.
NCT03678324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03678324 about?
NCT03678324 is a clinical study titled "Pre-Clinical White Matter Changes and Associated Connectivity Effects in Fabry Disease". The purpose of this research project is: * to use an advanced quantitative MRI technique (FBFI) to detect and quantify brain lesion in patients with FD * to use fMRI to identify altered brain function * to use FBFI and fMRI together to map altered connectivity in response to brain lesions
What is the current status of trial NCT03678324?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-01-27. Estimated completion is 2022-03-30.
What interventions are being tested in trial NCT03678324?
The interventions under investigation include: Functional MRI and fast bound-pool fraction imaging (OTHER).
Who is sponsoring clinical trial NCT03678324?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.